Related Experiment Video
Updated: Apr 12, 2026

06:48
CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
7.9K
RNA duplexes in transcriptional regulation
Biomolecular Concepts
|May 12, 2015
Summary
Small RNA molecules regulate gene expression through transcriptional gene silencing (TGS). This review covers RNA-mediated TGS mechanisms, epigenetic modifications, and RNA interference (RNAi) therapeutics in human trials.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- Small RNA molecules like small interfering RNA (siRNA) and microRNA are key regulators of gene expression.
- Transcriptional gene silencing (TGS) pathways, involving RNA-mediated mechanisms, are found across various organisms, including humans.
- Understanding these pathways is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To review current models of transcriptional regulation by small RNAs.
- To discuss the machinery of RNA-induced silencing complex (RISC) and RNA-induced transcriptional silencing complex (RITS).
- To explore RNA-mediated TGS in the context of HIV-1 and its epigenetic modifications, and to summarize RNA interference (RNAi) delivery methods and therapeutic trials.
Main Methods:
- Literature review of transcriptional regulation by small RNAs.
- Analysis of RNA-induced silencing complex (RISC) and RNA-induced transcriptional silencing complex (RITS) components.
- Examination of RNA-mediated TGS mechanisms, epigenetic modifications, and RNA interference (RNAi) delivery systems.
Main Results:
- Small RNAs significantly modulate gene expression via post-transcriptional and transcriptional gene silencing.
- RNA-mediated TGS involves specific complexes and can influence viral promoter regions and epigenetic states.
- Various RNAi delivery methods are being developed, with ongoing human trials for therapeutic applications.
Conclusions:
- Small RNA-mediated transcriptional gene silencing is a fundamental biological process with therapeutic potential.
- Further research into RNAi mechanisms and delivery is essential for advancing RNAi therapeutics.
- RNA interference holds promise for treating various human diseases.
Related Concept Videos
Cooperative Binding of Transcription Regulators
7.6K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.6K
Cooperative Binding of Transcription Regulators
2.7K
2.7K
Cis-regulatory Sequences
12.3K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
12.3K
Cis-regulatory Sequences
4.4K
4.4K
Co-activators and Co-repressors
9.0K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
9.0K
Co-activators and Co-repressors
3.3K
3.3K

